The CEO is the one who made reference to the next round of trials for our lead drug Bit225 will be phase 3 trials, and if Bit225 is targeting an unmet medical need for an added health benefit I think there is every chance it will be sold.
HYPED UP TO THE MAX, page-49
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.30M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 5.0¢ | 4.6¢ | $14.08K | 299.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6000 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 360439 | 1 |
View Market Depth
| Last trade - 15.33pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.7¢ |
Change
0.000 ( 4.08 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.7¢ | 4.7¢ | 59586 | ||
| Last updated 12.47pm 18/06/2024 ? | |||||
| BIT (ASX) Chart |